You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

DROXIDOPA - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for droxidopa and what is the scope of freedom to operate?

Droxidopa is the generic ingredient in two branded drugs marketed by Ajanta Pharma Ltd, Alkem Labs Ltd, Annora, Aurobindo Pharma Ltd, Bionpharma, Chartwell Rx, Hikma, Lupin Pharms, Msn Pharms Inc, Sciegen Pharms Inc, Somerset Theraps Llc, Sun Pharm, Teva Pharms Usa Inc, Upsher Smith Labs, Yampa, Zydus Pharms, and Lundbeck Na Ltd, and is included in seventeen NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for droxidopa. Sixteen suppliers are listed for this compound.

Summary for DROXIDOPA
Drug Prices for DROXIDOPA

See drug prices for DROXIDOPA

Recent Clinical Trials for DROXIDOPA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Kessler FoundationPhase 4
Loma Linda UniversityPhase 2
H. Lundbeck A/SPhase 2

See all DROXIDOPA clinical trials

Pharmacology for DROXIDOPA
Physiological EffectIncreased Blood Pressure
Medical Subject Heading (MeSH) Categories for DROXIDOPA

US Patents and Regulatory Information for DROXIDOPA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd DROXIDOPA droxidopa CAPSULE;ORAL 214387-002 Feb 18, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms DROXIDOPA droxidopa CAPSULE;ORAL 211818-001 Feb 18, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Teva Pharms Usa Inc DROXIDOPA droxidopa CAPSULE;ORAL 213162-002 Feb 18, 2021 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Zydus Pharms DROXIDOPA droxidopa CAPSULE;ORAL 211818-002 Feb 18, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.